Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Total Debt: 2022-2024

Historic Total Debt for Orchestra BioMed Holdings (OBIO) over the last 2 years, with Dec 2024 value amounting to $14.3 million.

  • Orchestra BioMed Holdings' Total Debt was N/A to $14.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year change of. This contributed to the annual value of $14.3 million for FY2024, which is N/A change from last year.
  • Orchestra BioMed Holdings' Total Debt amounted to $14.3 million in FY2024, which was up 23.43% from $11.6 million recorded in FY2022.
  • In the past 5 years, Orchestra BioMed Holdings' Total Debt ranged from a high of $14.3 million in FY2024 and a low of $11.6 million during FY2022.
  • Over the past 2 years, Orchestra BioMed Holdings' median Total Debt value was $12.9 million (recorded in 2022), while the average stood at $12.9 million.